Search clinical trials for: BNZ-1

Total 14640 results

Bioniz Therapeutics

Completed

A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL

LGL Leukemia | CTCL

United States
Bioniz Therapeutics
Celerion

Completed

A Multiple-Dose Study of Intravenous BNZ132-1-40 in Healthy Adult Subjects

Safety and Tolerability in Healthy Subjects

United States
Equillium

Withdrawn

Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areata

Alopecia Areata | Alopecia Totalis | Alopecia Universalis
Neuren Pharmaceuticals Limited

Completed

Safety Study of NNZ-2566 in Healthy Subjects, Following Oral Administration

Brain Injuries, Traumatic

Australia
Siemens Healthcare Diagnostics Inc

Terminated

Serial BNP Testing for Heart Failure Management (USE-BNP)

Heart Failure

United States, Canada
Bavarian Nordic
JPM CBRN Medical

Completed

Vaccination Trial of a Recombinant MVA-BN-WEV Vaccine in Healthy Adult Subjects

Equine Encephalitis

United States
Bionorica SE

Completed

Efficacy and Safety of a Herbal Medicinal Product (Dry Extract BNO 1016) in Patients With Acute Rhinosinusitis

Acute Rhinosinusitis

Germany
National Institute on Aging (NIA)

Completed

Bisnorcymserine in Healthy Adult Volunteers

Healthy Volunteers

United States
Blaze Bioscience Australia Pty Ltd

Completed

Safety Study of a Fluorescent Marker to Visualize Cancer Cells

Skin Neoplasms

Australia
Yale University

Completed

Combination SBIRT for Emergency Department Patients Who Drink and Smoke

Smoking | Drinking

United States
UCB Biopharma SRL

Active, not recruiting

A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis (BE MOVING)

Ankylosing Spondylitis | Axial Spondyloarthritis | r-axSpa | Nr-axSpa

United States, Belgium, Bulgaria, China, Czechia, France, Germany, Hungary, Japan, Netherlands, Poland, Spain, Turkey, United Kingdom
UCB Biopharma SRL

Terminated

A Study to Evaluate the Bioequivalence of Bimekizumab Given as 1x2mL or 2x1mL Subcutaneous Injection in Healthy Study Participants

Healthy Study Participants

Germany
Biosite

Completed

Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT II)

Heart Failure

United States
Spanish Cooperative Group for the Treatment of...
Hoffmann-La Roche

Completed

Selecting Treatment in Colorectal Cancer:Capecitabine or 5-fluorouracil Selection to be Combined With Oxaliplatin or Irinotecan as First-line Chemotherapy in Advanced Colorectal Cancer (SETICC)

Colorectal Cancer

Spain
Neuren Pharmaceuticals Limited

Completed

To Evaluate the Safety, Tolerability and Pharmacokinetics of Oral NNZ-2591 in Healthy Volunteers

Healthy Volunteers

Australia
Ben marzouk Sofiene

Completed

Placenta Accreta New Detection Procedure by Rapid Assessment of Serum BNP (PANDORA)

Placenta Accreta | Placenta Previa | Normal Pregnancy

Tunisia
UCB Biopharma S.P.R.L.

Completed

A Study to Compare the Blood Level of Bimekizumab Injected Subcutaneously Either by a Prefilled Syringe or by an Auto-injector in Adult Healthy Volunteer Participants

Healthy Volunteers

United States, Germany
Centre Hospitalier Universitaire de Nice

Completed

Preoperative BNP as Biomarker of Postoperative Cardiovascular Complications (BNP)

Postoperative Cardiovascular Complications
Philips Handheld Diagnostics

Completed

Determining Normal Values of BNP Levels for the Minicare BNP IVD Assay.

Healthy

Netherlands
University of Sao Paulo
University of Sao Paulo General Hospital

Completed

B-type Natriuretic Peptide in the Diagnosis of Heart Failure Related Ascites

Liver Cirrhosis | Heart Failure | Ascites | Carcinomatosis

Brazil
Blaze Bioscience Inc.
National Cancer Institute (NCI)

Withdrawn

Safety Study of BLZ-100 in Adult Subjects With Sarcoma Undergoing Surgery

Sarcoma, Soft Tissue

United States
Blaze Bioscience Inc.

Completed

Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing Surgery

Tumors, Breast

United States
Parkview Health

Withdrawn

Comparison Study in Pancreatic Fiducial Placement

Pancreatic Neoplasms

United States
UCB Biopharma SRL

Active, not recruiting

A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis (BE VITAL)

Psoriatic Arthritis

United States, Australia, Belgium, Canada, Czechia, France, Germany, Hungary, Italy, Japan, Poland, Russian Federation, Spain, United Kingdom
UCB Biopharma SRL

Active, not recruiting

A Study to Assess the Pharmacokinetics, Safety, and Efficacy of Two Doses of Bimekizumab in Adolescent Study Participants With Moderate to Severe Plaque Psoriasis (BE CONNECTED)

Moderate to Severe Plaque Psoriasis

United States, Canada, Germany, Poland
UCB Biopharma SRL

Completed

A Bioequivalence Study of Bimekizumab Given as 1x2mL or 2x1mL Subcutaneous Injection Using an Autoinjector in Healthy Study Participants

Healthy Study Participants

United States, Germany
UCB Celltech

Completed

A Study to Evaluate the Relative Bioavailability and Tolerability of Bimekizumab in Healthy Subjects

Healthy Volunteers

United Kingdom
Anza Therapeutics, Inc.

Terminated

Study of Safety and Tolerability of Multiple Intravenous Doses of ANZ-521 in Adults With Chronic Hepatitis C Virus

Chronic Hepatitis C

United States
VA Office of Research and Development

Terminated

Metabolic Effects of Natriuretic Peptide Hormones (MENP)

Obesity | Metabolism | Cardiovascular Physiological Phenomena

United States
UCB Biopharma SRL

Completed

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Korean Study Participants With Moderate to Severe Plaque Psoriasis

Moderate to Severe Plaque Psoriasis

Korea, Republic of
Neuren Pharmaceuticals Limited

Completed

Safety Study of NNZ-2566 in Healthy Female Subjects

Brain Injuries, Traumatic

Australia
UCB Biopharma SRL

Completed

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Nonradiographic Axial Spondyloarthritis (BE MOBILE 1)

Nonradiographic Axial Spondyloarthritis

United States, Belgium, Bulgaria, China, Czechia, France, Germany, Hungary, Japan, Poland, Spain, Turkey, United Kingdom
Blaze Bioscience Inc.

Available

Expanded Access for BLZ-100 (Tozuleristide)
UCB Biopharma SRL

Completed

A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis (BE COMPLETE)

Psoriatic Arthritis

United States, Australia, Canada, Czechia, Germany, Hungary, Italy, Japan, Poland, Russian Federation, United Kingdom
Boston Medical Center
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Addressing Low-Income Families' Basic Social Needs at Pediatric Visits

Low Income Families Basic Social Needs

United States
Blaze Bioscience Inc.

Completed

Safety Study of BLZ-100 in Adult Subjects With Glioma Undergoing Surgery

Glioma

United States, Australia
Bayside Health
The Alfred

Unknown

BNP Testing in Patients With SOB on Presentation to ED

Heart Failure, Congestive

Australia
First Affiliated Hospital of Fujian Medical University

Unknown

68Ga-BNU-PSMA PET/CT in Patients With Various Types of Cancer

Metastasis | Tumor | Positron-Emission Tomography

China
ElMindA Ltd

Completed

Normative Data Base of Brain Network Activation (BNA) Using Evoked Response Potentials (Normative)

Normative

United States, India
Bionorica SE

Completed

Dose-dependent Effects of VAC BNO 1095 on Cyclic Mastodynia and Premenstrual Syndrome

Premenstrual Syndrome | Cyclic Mastodynia

Czech Republic
UCB Biopharma SRL

Completed

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing Spondylitis (BE MOBILE 2)

Ankylosing Spondylitis

United States, Belgium, Bulgaria, China, Czechia, France, Germany, Hungary, Japan, Netherlands, Poland, Spain, Turkey, United Kingdom
Blaze Bioscience Inc.

Completed

Study of BLZ-100 in Pediatric Subjects With CNS Tumors

Central Nervous System Tumors

United States
Assistance Publique - Hôpitaux de Paris

Completed

Septic cArdiac Deficiency and MenIngococcal seveRe Sepsis (SAMIRA)

Septic Shock | Meningococcal Infections | Severe Sepsis

France
Bionorica SE

Completed

Assessment of Skin Tolerance and Efficacy of a Cosmetic Product After 4 Weeks of Use on Subjects With Atopic Dermatitis

Eczema-Prone Skin | Atopic Diathesis

Germany
UCB Biopharma S.P.R.L.

Completed

A Study to Evaluate the Antibody Response of Influenza Vaccination Following Concomitant Exposure to Bimekizumab in Healthy Subjects

Healthy Volunteers

United States
University Hospital, Bordeaux
IPSEN PHARMA S.A.S

Completed

Restless Legs Syndrome Treatment With Botulinum Toxin (SOXIS)

Restless Legs Syndrome

France
Michael Hoelscher
Leibniz Institute for Natural Product Research and Infection Biology Hans...

Completed

Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment

Lung Diseases | Mycobacterium Infections | Tuberculosis | Tuberculosis, Pulmonary | Bacterial Infections Respiratory

Netherlands
Bangabandhu Sheikh Mujib Medical University, Dhaka...

Completed

Frequency and Magnitude of Subclinical Systolic Dysfunction by Strain Imaging in Heart Failure With Preserved Ejection Fraction

Heart Failure | Heart Failure With Preserved Ejection Fraction

Bangladesh
Centre Hospitalier René Dubos

Completed

Heart Failure Educational and Follow up Platform (HELP)

Chronic Heart Failure

France
Novartis Vaccines

Completed

Extension Study of V72P13 to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered as a Booster or as a Two-dose Catch-up to Healthy Toddlers

Meningococcal Disease

Austria, Finland, Germany, Italy, Czech Republic

Search clinical trials for: BNZ-1

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations